|Articles|March 1, 2002

Brand-name glaucoma drug offers cost-effective treatment

Ophthalmologists prescribing timolol hemihydrate (Betimol, Santen Pharmaceuticals) can be assured their patients are receiving a brand-name nonselective beta-blocker product that is safe, effective, and economical, said Michael S. Berlin, MD, and George A. Cioffi, MD.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.


Latest CME